Koyfin Home > Directory > Health Care > Pieris Pharma > Long-Term Debt

Pieris Pharma Long-Term Debt Chart (PIRS)

Pieris Pharma annual/quarterly Long-Term Debt from 2013 to 2014.
  • Pieris Pharma Long-Term Debt for the quarter ending September 09, 2014 was $5m
  • Pieris Pharma Long-Term Debt for the last 12 months ending September 09, 2014 was $5m
Other Cash Flow Metrics:
  • Pieris Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $-14m a 67.31% decrease of -10m year over year
  • Pieris Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-21m a 96.92% decrease of -20m year over year
  • Pieris Pharma Total Revenue for the quarter ending September 09, 2018 was $8m a -117.52% decrease of -10m year over year
View Chart On Koyfin

Quarterly PIRS Long-Term Debt Data

09/2014$5m
12/2013$5m

Annual PIRS Long-Term Debt Data

2013$5m